PEG Organ Protectant Resuscitation for Donor Perfusion Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for resuscitating brain dead organ donors face challenges in maintaining hemodynamic stability and preventing organ preservation injury, particularly due to the use of vasopressors and crystalloids, which can lead to complications such as acute tubular necrosis and decreased renal allograft function.
Innovation Solution
Administering an organ protectant solution containing polyethylene glycol polymers (PEG) with a molecular weight of 18,000-40,000 Da at 5-15% w/v to maintain mean arterial pressure and reduce cell swelling, thereby enhancing tissue perfusion and reducing the need for vasopressors and crystalloids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stress or pressure
If vasopressors and crystalloids are used for fluid resuscitation of brain dead organ donors, then mean arterial pressure can be maintained, but organ preservation injury occurs including acute tubular necrosis and decreased renal allograft function
Solution Approach 1:
The patent changes the chemical composition parameter of the resuscitation fluid by using PEG-20k (polyethylene glycol with molecular weight 20,000 Da) instead of traditional crystalloids or colloids. This parameter change allows maintenance of mean arterial pressure while avoiding the harmful effects of vasopressors and traditional resuscitation fluids on organ preservation
Solution Approach 2:
PEG-20k acts as an intermediary substance that provides volume expansion and hemodynamic support without the harmful side effects of traditional vasopressors and crystalloids. It mediates between the need for hemodynamic stability and the need to prevent organ injury by providing a alternative resuscitation agent with different physiological properties
2Productivity
If aggressive fluid resuscitation is performed to stabilize hemodynamics, then the number of organs for procurement increases, but the volume status must be carefully controlled to avoid lung injury
Solution Approach 1:
The patent changes the fluid composition parameter to PEG-20k which has different volume expansion characteristics and oncotic properties compared to traditional crystalloids. This allows more precise control of volume status during resuscitation, enabling aggressive fluid administration when needed while reducing the risk of pulmonary edema and lung injury
3Stress or pressure
If vasopressors are used to treat severe systemic hypotension, then mean arterial pressure is improved, but postoperative acute tubular necrosis and delayed graft function occur
Solution Approach 1:
PEG-20k serves as an intermediary resuscitation agent that provides hemodynamic support without the vasoconstrictive effects of traditional vasopressors. It maintains mean arterial pressure through volume expansion and improved microcirculation rather than systemic vasoconstriction, thereby preserving renal allograft function while achieving hemodynamic stability
Solution Approach 2:
The patent extracts the harmful vasoconstrictive component from the resuscitation approach by using PEG-20k instead of vasopressors. This separation allows maintenance of mean arterial pressure through non-vasoconstrictive mechanisms, eliminating the harmful effect on renal allograft function while preserving the beneficial hemodynamic support
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
PEG-20k solutions improve end organ preservation by maintaining superior perfusion and tissue volume control, reducing preservation injury, and enhancing the quality of organs for transplantation.
Implementation Method 1
administering intravenously to said organ donor an organ protectant solution comprising polyethylene glycol polymers (PEG) with a molecular weight of 18,000-40,000 Da at a concentration of 5-15% w/v
Data Source
AI summary
Provided herein are methods for fluid resuscitation of an organ donor. The method includes administering intra-venously to the organ donor an organ protectant solution comprising polyethylene glycol polymers (PEG) with a molecular weight of 18,000-40,000 Da at a concentration of 5-15% w/v. The methods are suitable for protecting organs prior to transplantation.